PFIZER INC Share-based Payment Arrangement, Expense, after Tax
PFIZER INC (PFE) reported Share-based Payment Arrangement, Expense, after Tax of $350.00 million for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax · last filed 2014-02-28
- PFIZER INC share-based payment arrangement, expense, after tax for fiscal 2013 was $350.00M, a 5.42% increase from fiscal 2012.
- PFIZER INC share-based payment arrangement, expense, after tax for fiscal 2012 was $332.00M, a 18.57% increase from fiscal 2011.
- PFIZER INC share-based payment arrangement, expense, after tax for fiscal 2011 was $280.00M, a 1.45% increase from fiscal 2010.
- PFIZER INC share-based payment arrangement, expense, after tax for fiscal 2010 was $276.00M, a 10.40% increase from fiscal 2009.
| Period end | Share-based Payment Arrangement, Expense, after Tax 12 month |
|---|---|
| 2013-12-31 | $350.00M 10-K · filed 2014-02-28 |
| 2012-12-31 | $332.00M 10-K · filed 2014-02-28 |
| 2011-12-31 | $280.00M 10-K · filed 2014-02-28 |
| 2010-12-31 | $276.00M 10-K · filed 2013-02-28 |
| 2009-12-31 | $250.00M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |